Accurate diagnosis of COVID-19 infection is a crucial tool to identify and control the spread of the disease. Current frontline technology, based on Reverse Transcription Polymerase Chain Reaction (RT-PCR), can depend on getting an adequate sample from the patient. If the sample collected does not have enough viral material on it, either because of the collection method or because of the stage of the infection, it can affect the result. RT-PCR also requires well equipped laboratories and specialized human resources. The technology being proposed uses Artificial Intelligence (AI) to analyze Chest X-Rays (CXR) to identify signs of disease at a very early stage and to monitor disease progression. The technology has multiple uses, from hospital settings to large public health screenings. It also has the potential to be applied to other pathologies.
Journal: TechConnect Briefs
Volume: TechConnect Briefs 2021
Published: October 18, 2021
Pages: 165 - 168
Industry sector: Medical & Biotech
Topics: Biomaterials, Diagnostics & Bioimaging